San Diego-centered Viking Therapeutics marked itself as a significant competitor during the weight loss drug market place in February immediately after revealing promising info from the mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection and in Marc